CHARACTERISTICS OF MYOCARDIAL DAMAGE DURING COVID-19 IN CHILDREN: REMOTE CONSEQUENCES, REHABILITATION APPROACHES
https://doi.org/10.52485/19986173_2022_2_64
Abstract
Taking into account the existing knowledge about heart damage in the case of a new coronavirus infection in children, there are many gaps and vulnerabilities that can cause new problems or exacerbate old ones. Since the disease is relatively young, it takes a lot of time to fully study its characteristics.
Complications from the cardiovascular system in children give an opportunity to think about the impact on the further development of the child's body. The world medical community at this stage of the development of the disease gathers the acquired experience together and contributes to the development of new methods of treatment and rehabilitation.
About the Authors
A. G. Oparina
Chita State Medical Academy
Russian Federation
Russian Federation
39A Gorky str., Chita, Russia, 672000
A. B. Dolina
Chita State Medical Academy
Russian Federation
Russian Federation
39A Gorky str., Chita, Russia, 672000
I. K. Bogomolova
Chita State Medical Academy
Russian Federation
Russian Federation
39A Gorky str., Chita, Russia, 672000
References
1. Chang L.Y., Lu C.Y., Chao P.L. Viral infection associated with Kawasaki disease. Journal of the Formosan Medical Association. 2014. 113 (3). 148–154. DOI: 10.1016/j.jfma.2013.12.008.
2. Namazova-Baranova L.S., Baranov A.A. COVID-19 and children. Pul'monologiya. 2020. 30 (5). 609–628. DOI: 10.18093/0869-0189-2020-30-5-609-628. In Russian.
3. Meo S.A., Alhowikan A.M., Al-khlaiwi T., Meo I.M., Halepoto D.M., Iqbal M., Usmani A.M., Hajjar W., Ahmed N. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. European Review for Medical and Pharmacological Sciences. 2020. 24 (4). 2012-2019. DOI: 10.26355/eurrev_202002_20379.
4. Shchelkanov M.Yu., Popova A.Yu., Dedkov V.G., Akimkin V.G., Maleev V.V. History of the study and modern classification of coronaviruses. Infektsiya i immunitet. 2020. vol. 10. no. 2. 221–246. In Russian.
5. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int.J. Antimicrob. Agents. 2020. DOI: 10.1016/j.ijantimicag.2020.105924.
6. Gorbalenya A.E. Severe acute respiratory syndrome-related coronavirus — The species and its viruses, a statement of the Coronavirus Study Group. Nature Microbiology. 2020. № 2. DOI: 10.1038/s41564-020-0695- з.
7. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https://coronavirus.jhu.edu/map.html.
8. Becker R.C. COVID-19 update: Covid-19-associated coagulopathy. Journal of Thrombosis and Thrombolysis. 2020. 50. 54–67.
9. Libby P., Luscher T. COVID-19 is, in the end, an endothelial disease. European Heart Journal. 2020. 41. 3038–3044.
10. Abakushina E.V. Immunological aspects of coronavirus disease caused by SARS-COV-2. Meditsinskiy radiologicheskiy nauchnyy tsentr im. A.F. Tsyba. Geny & Kletki. Tom XV №3. 2020. DOI: 10.23868/202011002. In Russian.
11. Pons S., Fodil S., Azoulay E., Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Critical Care Medicine. 2020.24. 353.
12. Chernyago T.Yu., Fomina V.S., Fedyk O.V., Yashkin M.N. Methods for assessing the functional state of the endothelium in patients with varicose veins of the lower extremities: prospects of therapeutic tactics. Vestnik natsional'nogo mediko-khirurgicheskogo tsentra imeni N.I. Pirogova. 2021.16(1).145–150. DOI: 10.25881/BPNMSC.2021.17.48.028. In Russian.
13. Mishra A. K., Sahu K. K., George A. A., Lal A. A review of cardiac manifestations and predictors of outcome in patients with COVID–19. Heart & Lung. 49. 848. DOI:1016/j.hrtlng.2020.04.019.2020.
14. Guo T., Fan Y., Chen M. Cardiovascular Implications of Fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. 5(7). 811-818. DOI: 10.1001/jamacardio.2020.1017.
15. Lindner D., Fitzek A., Bräuninger H. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020. 5 (11). 1281-1285. DOI: 10.1001/jamacardio.2020.3551.
16. Dennis A., Wamil M., Kapur S., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., Attree E., Heightman M., Banerjee R., Banerjee A. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. MedRxiv. 2021. 11(3). e048391. DOI: 10.1136/bmjopen-2020-048391.
17. Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. medRxiv. 2021. 372. n693. DOI: 10.1136/bmj.n693.
18. Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. The New England Journal of Medicine. 2020. 383 (2). 120-128. DOI: 10.1056/NEJMoa2015432.
19. Teuwen L.A., Geldhof V., Pasut A., Carmeliet P. COVID-19: the vasculature unleashed. Nature Reviews Immunology. 2020. 20(7). 389-391. DOI: 10.1038/s41577-020-0343-0.
20. Lu X., Zhang L., Du H., Zhang J., Li Y., Qu J., Zhang W., Wang Y., Bao S., Li Y., Wu C., Liu H., Liu D., Shao J., Peng X., Yang Y., Liu Z., Xiang Y., Zhang F., Silva R.M., Pinkerton K.E., Shen K., Xiao H., Xu S., Wong G.W.K.. SARS-CoV-2 Infection in Children. The New England Journal of Мedicine. 2020. 382 (17). 1663–1665. DOI: 10.1056/NEJMc2005073/
21. Paediatric Intensive Care Society. PICS Statement regarding novel presentation of multi- system inflammatory disease. Available from: https://pccsociety.uk/news/pics-statement-regarding-novel-presentation-of-multisystem-inflammatory-disease.
22. Bruna G.G. Pinto, Antonio E.R. Oliveira, Youvika Singh, Leandro Jimenez, Andre N.A. Gonçalves, Rodrigo L.T. Ogava, Rachel Creighton, Jean Pierre Schatzmann Peron. ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19.The Journal of Infectious Diseases. 2020. DOI: 10.1093/infdis/jiaa332.
23. Ivanov O.B., Bukhval'd E.M. National Security of Russia: new challenges and new priorities. Etap: ekonomicheskaya teoriya, analiz, praktika. 2021. Available from: https://cyberleninka.ru/article/n/natsionalnaya-bezopasnost-rossii-novye-problemy-i-novye-prioritety/viewer. In Russian.
24. Medical rehabilitation for new coronavirus infection (COVID-19). Vremennye metodicheskie rekomendatsii (utv. Minzdravom Rossii).Versiya 2 (31.07.2020). Available from: https://static- minzdrav.gov.ru/system/attachments/attaches/000/051/187/original/31072020_Reab_COVID-19_v1.pdf. In Russian.
25. Kolesnikova N.V., Kondrat'eva E.I., Nesterova I.V., Gaprindashvili E.G., Ponomarenko Yu.B., Asekretova T.V., Chudilova G.A., Lomtatidze L.V. Age and sex characteristics of some cytokines in the blood of healthy children. Kubanskiy nauchnyy meditsinskiy vestnik № 6 (129). 2011. In Russian.
26. Kozlov I.A., Tyurin I.N. Cardiovascular complications of COVID-19.Vestnik anesteziologii i reanimatologii. Tom 17. № 4. С. 14-22. 2020. DOI: 10.21292/2078-5658-2020-17-4-14-22. In Russian.
27. Boytsov S.A. Influenza, new coronavirus infection and cardiovascular diseases. Kardiologicheskiy vestnik. 2021. 16(1). 5–9. DOI: 10.17116/Cardiobulletin2021160115. In Russian.
28. Myocarditis in children. (Approved by the Union of Pediatricians of Russia). Klinicheskie rekomendatsii. 2016 г. Available from: https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/Миокардит%20дети%20СПР.v2.pdf. In Russian.
29. Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020. 395 (10237). 1607–1608. DOI: 10.1016/S0140-6736(20)31094-1.
30. Ramcharan T., Nolan O., Lai C.Y., Prabhu N., Krishnamurthy R., Richter A.G., Jyothish D., Kanthimathinathan H.K., Welch S.B., Hackett S., Al-Abadi E., Scholefield B.R., Chikermane A. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatric Cardiology. 2020. 41(7). 1391-1401. DOI: 10.1007/s00246-020-02391-2.
31. Degtyareva E.A. COVID-19, postcovid syndrome and children's heart. StatusPraesens №4 (82) 12. 2021. С 53. In Russian.
32. Long Covid: what is it, and what is needed? London: Royal Society. 23 October 2020.
33. Dennis A., Wamil M., Kapur S., Alberts J., Badley A.D., Decker G.A., Rizza C.A., Banerjee R., Banerjee A.. Multi-organ impairment in low-risk individuals with long COVID. BMJ Open. 2021. 11 (3). e048391. DOI: 10.1136/bmjopen-2020-048391.
34. WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus: World Health Organization. 2021. Available from: https://covid19.who.int/, accessed 6 October 2021.
35. American Heart Association. "Heart function recovered quickly in children with COVID-19- related MIS-C condition." ScienceDaily. ScienceDaily. 19 January 2022. Available from: https://www.sciencedaily.com/releases/2022/01/220119090859.htm
36. Medical rehabilitation in case of a new coronavirus infection (COVID-19). Vremennye metodicheskie rekomendatsii (utv. Minzdravom Rossii). Versiya 1 (21.05.2020). Available from: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/187/original/31072020_Reab_COVID-19_v1.pdf.
37. Chronic heart failure in children. Clinical guidelines. (Approved by the Union of Pediatricians of Russia). 2016 г. Available from: https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/ХСН%20дети%20СПР.v1.pdf. In Russian.
38. Ruzhentsova T.A., Gorelov A.V. Possibilities of cardiometabolic therapy of infectious myocarditis and cardiomyopathies in children. «Praktika pediatra».2012. с. 50-55. In Russian.
39. Vertkin A.L., Shishkova V.N., Sycheva A.S., Kebina A.L., Nosova A.V., Uryanskaya K.A., Gazikova Kh.M., Zav'yalov G.V. Possibilities of metabolic support in coronavirus infection. Terapiya №7. 2020. DOI: https://dx.DOI:.org/10.18565/therapy.2020.7.146-155. In Russian.
40. Peregoedova V.N., Bogomolova I.K., Babkin A.A. A new coronavirus infection in the practice of a pediatrician. Zabaykal'skiy meditsinskiy vestnik. 2021. DOI: 10.52485/19986173_2021_4_112. In Russian.
Review
For citations:
Oparina A.G., Dolina A.B., Bogomolova I.K. CHARACTERISTICS OF MYOCARDIAL DAMAGE DURING COVID-19 IN CHILDREN: REMOTE CONSEQUENCES, REHABILITATION APPROACHES. Transbaikalian Medical Bulletin. 2022;(2):64-78. (In Russ.) https://doi.org/10.52485/19986173_2022_2_64
Views:
121
Email this article 